Indefinite Delivery Contract SPE2DU25D9379

The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal government agencies. The $4,999,999 IDC, valid through December 2036, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

This IDC is part of DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which seeks to establish multiple regional prime vendor contracts with a total estimated value of $30.3 billion. The PPV-G GEN V program provides worldwide pharmaceutical support to the Defense Health Agency, DoD customers, the U.S. Coast Guard, and other government agencies, including during planned and unplanned contingencies. The unrestricted solicitation is expected to be issued in March 2024, with awards made on a regional basis to at least three different contractors.